Merck, Glenmark Antitrust MDL Must Go To Jury, Judge Says
A Virginia magistrate judge has recommended denying Merck and Glenmark's bids to end antitrust multidistrict litigation accusing the drugmakers of conspiring to delay generic competition for the branded cholesterol medication Zetia,...To view the full article, register now.
Already a subscriber? Click here to view full article